Growth Metrics

Johnson & Johnson (JNJ) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $33.0 million.

  • Johnson & Johnson's Gains from Investment Securities rose 10625.0% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $171.0 million, marking a year-over-year increase of 865000.0%. This contributed to the annual value of $174.0 million for FY2024, which is 155000.0% up from last year.
  • Per Johnson & Johnson's latest filing, its Gains from Investment Securities stood at $33.0 million for Q3 2025, which was up 10625.0% from $36.0 million recorded in Q2 2025.
  • Johnson & Johnson's 5-year Gains from Investment Securities high stood at $297.0 million for Q3 2021, and its period low was -$185.0 million during Q1 2023.
  • For the 5-year period, Johnson & Johnson's Gains from Investment Securities averaged around $34.3 million, with its median value being $31.5 million (2025).
  • In the last 5 years, Johnson & Johnson's Gains from Investment Securities tumbled by 8558.56% in 2024 and then skyrocketed by 50000.0% in 2025.
  • Johnson & Johnson's Gains from Investment Securities (Quarter) stood at $16.0 million in 2021, then soared by 268.75% to $59.0 million in 2022, then tumbled by 276.27% to -$104.0 million in 2023, then skyrocketed by 169.23% to $72.0 million in 2024, then plummeted by 54.17% to $33.0 million in 2025.
  • Its Gains from Investment Securities was $33.0 million in Q3 2025, compared to $36.0 million in Q2 2025 and $30.0 million in Q1 2025.